Kong Jing, M.D.

Department:Endocrinology

Medical School:Peking Union Medical College, China

Academic Rank:Associate Chief Physician

Appointment

Clinical / Research Interests

Diabetes, obesity and metabolic syndrome.

Metabolic bone diseases, including osteoporosis, parathyroid diseases, Vitamin D deficiency, osteomalacia (rickets), etc.

Thyroid disease, pituitary and adrenal diseases.

Professional Appointments

Youth Committee member, Osteoporosis And Bone Mineral Research Branch, Zhejiang Medical Association

Publications

Kong J, Lai J, Wang M, Xie Y, He H, Gu J, Pan T, Lu Z. Jiang L. A Glutathione-Consuming Bimetallic Nano-Bomb with the Combination of Photothermal  and Chemodynamic Therapy for Tumors: An in vivo and in vitro Study. Int J Nanomedicine, 2024. 19: p. 8541-8553.

Hu Y, Ye S, Kong J, Zhou Q, Wang Z, Zhang Y, Yan H, Wang Y, Li T, Xie Y, Chen B, Zhao Y, Zhang T, Zheng X, Niu J, Hu B, Wang S, Chen Z, Zheng C. DOT1L protects against podocyte injury in diabetic kidney disease through  phospholipase C-like 1. Cell Commun Signal, 2024. 22(1): p. 519.

Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X. Clinical and genetic analysis of multiple endocrine neoplasia type 1-related primary hyperparathyroidism in Chinese. PLos ONE. 2016;11(11):e0166634.

Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese. Clinical Endocrinology. 2014; 81(2):222-30.

Find People

Search by Family Name

Find A Department

Search by Departments